Nasus Pharma Ltd (NSRX) stock
NSRXNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 25, 2026Score 6/30
$2.61−0.05 (-1.88%)
Close on Nov 17, 2026Market cap $23.53MP/E –Yield –
Nasus Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Nasus Pharma's enterprise value was $15.49M on Nov 11, 2026, against $51.34M a year earlier.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $15.49M | -76.9% |
| 2025 | Dec 31, 2025 | $67.17M | – |
See a number that looks wrong?